Experienced Director of Field Medical with advanced degree, 20+ years of expertise in Medical Affairs, Research and Development, Managed Care, and Sales. Demonstrated success in KOL development, performance management processes, and cross-functional Medical Affairs coordination, team leadership, growth driving, and strategic initiative implementation across diverse therapeutic areas, product launches, and cross-functional team communication. Solid clinical healthcare background with advanced skills in medical information, customer service, clinical trial management, and health economics outcomes research. Proficient in managing cross-functional projects, fostering collaboration, and delivering results through strong leadership and communication abilities.
Hi, I’m
Tiffany Reinders, MD
National Director Of Field Medical-Medical Affairs
Omaha,US
Summary
Overview
10
Certificates
2026
years of professional experience
10
years of post-secondary education
Work History
Inovio Pharmaceuticals, Inc.
National Director, Field Medical Affairs
09.2025 - 02.2026
Job overview
- Developed and executed strategic and tactical plans aligned with corporate Medical Affairs strategy, achieving 100% on-time delivery of launch readiness milestones.
- Directed national Field Medical Affairs strategy across 12 field-medical professionals (6 MSLs and 6 CDLs) supporting pipeline and marketed immunotherapy assets.
- Oversaw a $5M+ departmental budget, maintaining forecast accuracy within 3% variance and ensuring full compliance with corporate financial standards.
- Defined and implemented a comprehensive KPI framework tracking KOL engagements, insight generation, and education program outcomes, enabling data-driven performance reviews.
- Drove identification and engagement with 50+ national and regional KOLs across target disease areas, resulting in a 25% increase in verified expert relationships.
- Ensure scientific, medical/clinical, and operational excellence through performance management processes including annual reviews, succession planning, and real-time field reports based on regular field travel and data analysis.
- Lead development and implementation if training program for Inovio's drug-device combination including use of device and proper administration.
- Translate medical strategic priorities into clear field medical goals objectives, and initiatives with clear, defined, time bound KPIs and metrics.
- Lead Medical Affairs engagement with payers and managed care decision-makers.
- Maintain clinical and technical expertise in the therapeutic area through review of the scientific/medical literature and attendance at scientific meetings.
- Lead the development and execution of external engagement and educational strategies for centers of excellence, HSP/s and thought leaders.
- Developed and delivered high-impact scientific presentations to healthcare professionals (HCPs) and advisory boards, maintaining >95% satisfaction scores from internal feedback surveys.
- Enhanced cross-functional collaboration with Clinical Operations, Medical Information, and Market Access, providing quarterly actionable insights that shaped trial site strategy and payer engagement approaches.
- Direct field-based Medical Affairs to continued excellence.
Dendreon
Head of Field Medical
02.2024 - 09.2025
Job overview
- Built and managed a national team of 12 MSLs covering all U.S. regions; implemented structured onboarding and coaching programs that improved competency achievement timelines by 30%.
- Ensured compliance with regulatory guidelines and proper documentation of HCP interactions in Veeva CRM, maintaining 100% audit readiness.
- Designed and executed Field Medical strategy aligned with corporate and departmental goals, achieving >90% of key field performance metrics (KOL outreach, follow-ups, insight submission rates).
- Combined quantitative and qualitative KPIs in dashboards for a comprehensive view of MSL performance and impact. Included measures like quality of KOL relationships, impact of scientific exchanges (e.g., changes in clinical practice), and feedback from KOLs and internal stakeholders.
- Supported expansion of PROVENGE® (sipuleucel‑T), coordinating with clinical, commercial, and access teams to reach 2,000+ treatment centers and ensure full scientific coverage nationwide. First FDA-approved cellular immunotherapy for prostate cancer, which has been administered to nearly 40,000 men and managing patients throughout the continuum of prostate cancer PSA, DRE, PSMA PET with immunotherapy.
- Fostered collaboration between medical, nursing, and reimbursement teams to ensure favorable clinical and business outcomes, supporting both patient access and organizational growth. Worked closely with Commercial and Marketing teams to develop compliant scientific materials and training programs for product launches, ensuring all messaging was accurate and aligned with the latest clinical data while maintaining clear boundaries between promotional and educational activities.
- Introduced integrated KPI dashboards combining quantitative and qualitative measures, improving leadership visibility and driving a 20% increase in actionable insights submitted per quarter.
- Collaborated with Clinical Development on 15+ investigator-initiated and company-sponsored trials, ensuring scientific alignment and accelerating protocol amendments through real-world feedback.
- Lead programs focused on improving patient access, education, and support, ensuring therapies reached underserved and niche populations.
- Partnered with PV and Medical Information for SRL and follow up.
- Supported compliant cross-functional collaboration with Sales, Marketing, and PV; led training sessions for 200+ commercial colleagues to ensure scientific accuracy and compliance during launch phases.
- Championed programs to boost patient access and education, contributing to a 15% increase in eligible patient enrollment across major cancer centers.
- Cultivated leadership accountability through real-time field analytics and personal development plans, resulting in 95% team retention during period of organizational change.
Fresenius Kabi
Associate Director Medical Field Team & Med Info
07.2023 - 01.2024
Job overview
- Managed the launch of 4 oncology biosimilars in the U.S., coordinating cross‑functional efforts that achieved 100% launch readiness milestones and expanded access to affordable therapies in oncology and autoimmune disease.
- Recruited, trained, and mentored a national team of 16 oncology MSLs, improving field coverage efficiency by 25% and achieving >90% KPI goal attainment on KOL engagement and insight generation.
- Supported global expansion of key biosimilars (Tyenne®, Idacio®, Stimufend®), contributing to a 40% increase in international adoption rates across 40+ countries.
- Directed field medical strategy, training, and data analytics; implemented KPI dashboards that reduced report turnaround time by 35% and improved insight quality ratings by 20%.
- Established ongoing coaching and mentorship programs that improved MSL presentation quality scores from internal peer reviews by 30%.
- Partnered with Clinical, Regulatory, and Commercial teams to deliver compliant, evidence‑based scientific content, ensuring 100% audit compliance across all materials.
- Streamlined field operations to reduce administrative burden by ~25%, while maintaining consistent budget alignment and accurate forecasting.
- Strengthened alliances with external stakeholders and KOLs, driving a 15% year‑over‑year increase in scientific engagements and investigator interest in upcoming trials.
Mycovia Pharmaceuticals, Formerly Viamet Pharma
Associate Director, Field Medical and Medical Info
07.2020 - 06.2023
Job overview
- Founding leader establishing Medical Science Liaison, Medical Education, and Medical Information functions for a new pharmaceutical company specializing in women’s health and infectious disease.
- Managed 15 direct and 13 matrix reports, overseeing alliances and programs with an annual operating budget exceeding $15M, maintained within 2% variance to forecast.
- Organized cross‑functional integration between Medical Affairs, Clinical Development, and Commercial, driving 100% alignment of launch and publication planning timelines.
- Directed publication strategy that delivered 3 major peer‑reviewed articles, 5 abstracts, and multiple conference posters—amplifying Mycovia’s scientific visibility pre‑launch.
- Facilitated Good Clinical Practice Steering Committee and multiple internal medical governance bodies, improving protocol review cycle time by 20%.
- Designed and implemented company‑wide performance metrics for Medical Affairs team, tracking field engagement, insights, and publication output—driving a 35% increase in goal achievement rates.
- Spearheaded new best practices in field excellence and insight translation, resulting in 50+ data‑driven strategy adjustments to support global expansion initiatives.
- Established structured mentoring and career‑pathing programs, raising team retention to >95% and accelerating leadership readiness within 12 months.
The Medicines Company
Executive Senior Medical Science Liaison
10.2019 - 07.2020
Job overview
- Pre-launch siRNA (small interfering RNA class)/Cardiovascular
- Represent and report for The Medicines Company at International and National Scientific Congresses-liaison to American College of Cardiology (ACC), European Society of Cardiology (ESC), American Heart Association (AHA), National Lipid Association (NLA) and Familial Hypercholesterolemia Foundation Global Summit (FHF). Facilitated >50 interactions with KOLs and attendees at each congress event.
- Establish and maintain credible peer-to-peer scientific relationships with national and top regional opinion leaders, Supported at least 10 scientific presentations or symposia weekly.
- Produced >25 actionable scientific insights per quarter that led to adjustments in medical strategy or new research opportunities.
- Led/co-moderated advisory boards with 10–20 participating physicians per session.
- Support clinical trials research
- Work in collaboration with internal teams to pair key customer's education and research needs with potential clinical trial placement
- Partner with important customers including thought leaders, large group practices, medical directors and with national and top regional opinion leaders
- Achieved company growth by implementing strategic marketing plans and business development initiatives.
- Reviewed employee concerns and new opportunities to drive business strategies.
AHA Biologics
Senior Medical Scientific Liaison
08.2016 - 10.2019
Job overview
- Worked with 6 different drug/devices in various medical fields (Praluent, Multaq, Pradaxa, Ajovy, Copaxone, Austedo)
- Liaison to American Headache Society (AHS), American Pain Society (APS), American Academy of Neurology (AAN) and American Heart Association (AHA).
- Develop slide decks for site visit presentations and site education for physicians and nurses
- Acted as the liaison between upper management and staff members, promoting positive working relationships built on trust.
- Served as the primary point of contact, fostering strong relationships between internal teams and external partners.
- Supported organizational growth through active participation in networking events, conferences, and professional associations.
- Maintained a high degree of professionalism at all times, representing the organization with integrity in both internal and external interactions.
- Coordinated multiple projects simultaneously, ensuring timely completion and alignment with organizational objectives.
- Established effective communication channels between departments by organizing and facilitating cross-functional meetings.
- Successfully communicated with entities inside and outside of business.
- Aided in the development of training materials, contributing to the ongoing education of team members and improved performance outcomes.
- Evaluated customer needs and feedback to drive product and service improvements.
Novo Nordisk Inc
Diabetes Care Specialist II
2012 - 2016 (4 education.years_Label)
Job overview
- Experienced in injectables, orals, buy and bill. Proficient in Specialty Pharmacy Selling Proficient in New Launch of Drugs and Medical Devices.
- Overall – 128% Year to Date Overall Bonus Attainment
- 2015: Ranked in the Top 12% for product portfolio
- 2015: Launched Tresiba on Specialty Endocrinologist Team
- 2015: Managed DCS Solutions Team
- 2014: Chairman's Circle for Leadership Excellence
- 2014: 115% market growth in rural market driven by regaining relationship with high volume HCP's / KOL's
- 2014: Regional Mentor Program on WINN Team and Business Review Member for Northern Plains Region
- 2013: Circle of Excellence Winner- ranked- #1 in region and area and #3 in nation in lead product Levemir
- 2013: Goal Attainment of 105% for second position product Victoza
Education
Ross University School of MedicineNew York
M.D. from Basic Sciences And Advanced Clinical Medicine
08.2000 - 05.2004
University Overview
Accreditation Council For Medical Affairs (AACA)Oradell, NJ
Board Certification Medical Affairs (BCMAS) from Medical Affairs
06.2018 - 06.2019
University Overview
Mid-Plains Community CollegeNebraska
Master of Science from Emergency Medical Services
01.2001 - 01.2002
University Overview
Masters of Science in Emergency Medical Services, Paramedicine and Emergency Medicine
Hastings CollegeNebraska
Bachelor of Arts from Biology, Chemistry
08.1995 - 05.1999
University Overview
Skills
Performance management and succession planning
Regulatory and compliance oversight
Field-based medical strategy execution
Material management and resource optimization
Stakeholder engagement
Effective decision-making
Negotiation skills
Cultivating collaborative partnerships
Scientific Expertise
Strong presentation skills
Effective verbal communication
Collaborative teamwork and partnerships
Certification
Board Certification Medical Affairs (BCMAS)
Timeline
National Director, Field Medical Affairs
Inovio Pharmaceuticals, Inc.
09.2025 - 02.2026
Head of Field Medical
Dendreon
02.2024 - 09.2025
Associate Director Medical Field Team & Med Info
Fresenius Kabi
07.2023 - 01.2024
Associate Director, Field Medical and Medical Info
Mycovia Pharmaceuticals, Formerly Viamet Pharma
07.2020 - 06.2023
Executive Senior Medical Science Liaison
The Medicines Company
10.2019 - 07.2020
Accreditation Council For Medical Affairs (AACA)
Board Certification Medical Affairs (BCMAS) from Medical Affairs
06.2018 - 06.2019
Senior Medical Scientific Liaison
AHA Biologics
08.2016 - 10.2019
Mid-Plains Community College
Master of Science from Emergency Medical Services
01.2001 - 01.2002
Ross University School of Medicine
M.D. from Basic Sciences And Advanced Clinical Medicine
08.2000 - 05.2004
Hastings College
Bachelor of Arts from Biology, Chemistry
08.1995 - 05.1999
Diabetes Care Specialist II
Novo Nordisk Inc
2012 - 2016 (4 education.years_Label)
Software
Veeva
Salesforce
Kapture
Product Launches and Therapies
Product Launches and Therapies
Oncology / Immunology / Cardiology / Emergency /Autoimmune / Immune-Mediated / Endocrinology / GI / GU / Neurology / Pain / Men's Health / Women's Health / Rare / Orphan
- Tetrazole anti-fungal in Women's Health & Infectious Disease
- siRNA in Cardiovascular
- Humanized monoclonal antibody in Neurology
- Liraglutide in Obesity
- Non-steroidal anti-inflammatory and PPI combo in Gastrointestinal
- Glucagon-like-peptide 1 (GLP-1) in Endocrinology and Cardiovascular
- Insulin detemir long-acting human insulin in Endocrinology
- Acylated human glucagon- like-peptide-1 (GLP-1) in Endocrinology & Cardiovascular
- Insulin degludec long-acting insulin in Endocrinology
- Selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) in Men's Health
- Tocilizumab in Immunotherapy
- Rituximab in Immunotherapy
- Denosumab in Immunotherapy
Launched 18 Products/Devices
URL
URL
www.linkedin.com/in/tiffany-reinders
Product Launches and Therapies
Product Launches and Therapies
Oncology / Immunology / Cardiology / Emergency /Autoimmune / Immune-Mediated / Endocrinology / GI / GU / Neurology / Pain / Men's Health / Women's Health / Rare / Orphan
- Tetrazole anti-fungal in Women's Health & Infectious Disease
- siRNA in Cardiovascular
- Humanized monoclonal antibody in Neurology
- Liraglutide in Obesity
- Non-steroidal anti-inflammatory and PPI combo in Gastrointestinal
- Glucagon-like-peptide 1 (GLP-1) in Endocrinology and Cardiovascular
- Insulin detemir long-acting human insulin in Endocrinology
- Acylated human glucagon- like-peptide-1 (GLP-1) in Endocrinology & Cardiovascular
- Insulin degludec long-acting insulin in Endocrinology
- Selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) in Men's Health
- Tocilizumab in Immunotherapy
- Rituximab in Immunotherapy
- Denosumab in Immunotherapy
Launched 18 Products/Devices
URL
URL
www.linkedin.com/in/tiffany-reinders
URL
URL
www.linkedin.com/in/tiffany-reinders
Product Launches and Therapies
Product Launches and Therapies
Oncology / Immunology / Cardiology / Emergency /Autoimmune / Immune-Mediated / Endocrinology / GI / GU / Neurology / Pain / Men's Health / Women's Health / Rare / Orphan
- Tetrazole anti-fungal in Women's Health & Infectious Disease
- siRNA in Cardiovascular
- Humanized monoclonal antibody in Neurology
- Liraglutide in Obesity
- Non-steroidal anti-inflammatory and PPI combo in Gastrointestinal
- Glucagon-like-peptide 1 (GLP-1) in Endocrinology and Cardiovascular
- Insulin detemir long-acting human insulin in Endocrinology
- Acylated human glucagon- like-peptide-1 (GLP-1) in Endocrinology & Cardiovascular
- Insulin degludec long-acting insulin in Endocrinology
- Selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5) in Men's Health
- Immunology: Tocilizumab, Rituximab, Denosumab biosimilars with direct application to autoimmune and immune-mediated conditions
- INO-3107 in Oncology/Immunotherapy
- Launched 20 Products/Devices